Literature DB >> 22020726

An informed reference prior for between-study heterogeneity in meta-analyses of binary outcomes.

Eleanor M Pullenayegum1.   

Abstract

It is well known that when a Bayesian meta-analysis includes a small number of studies, inference can be sensitive to the choice of prior for the between-study variance. Choosing a vague prior does not solve the problem, as inferences can be substantially different depending on the degree of vagueness. Moreover, because the data provide little information on between-study heterogeneity, posterior inferences for the between-study variance based on vague priors will tend to be unrealistic. It is thus preferable to adopt a reasonable, informed prior for the between-study variance. However, relatively little is known about what constitutes a realistic distribution. On the basis of data from the Cochrane Database of Systematic Reviews, this paper describes the distribution of between-study variance in published meta-analyses, and proposes some realistic, informed priors for use in meta-analyses of binary outcomes. It is hoped that these priors will improve the calibration of inferences from Bayesian meta-analyses.
Copyright © 2011 John Wiley & Sons, Ltd.

Mesh:

Year:  2011        PMID: 22020726     DOI: 10.1002/sim.4326

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  20 in total

1.  A group-specific prior distribution for effect-size heterogeneity in meta-analysis.

Authors:  Christopher G Thompson; Betsy Jane Becker
Journal:  Behav Res Methods       Date:  2020-10

2.  Classifying information-sharing methods.

Authors:  Georgios F Nikolaidis; Beth Woods; Stephen Palmer; Marta O Soares
Journal:  BMC Med Res Methodol       Date:  2021-05-22       Impact factor: 4.615

3.  Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons.

Authors:  Fujian Song; Allan Clark; Max O Bachmann; Jim Maas
Journal:  BMC Med Res Methodol       Date:  2012-09-12       Impact factor: 4.615

4.  Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews.

Authors:  Rebecca M Turner; Jonathan Davey; Mike J Clarke; Simon G Thompson; Julian Pt Higgins
Journal:  Int J Epidemiol       Date:  2012-03-29       Impact factor: 7.196

5.  Bayesian model-averaged meta-analysis in medicine.

Authors:  František Bartoš; Quentin F Gronau; Bram Timmers; Willem M Otte; Alexander Ly; Eric-Jan Wagenmakers
Journal:  Stat Med       Date:  2021-10-27       Impact factor: 2.497

6.  Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.

Authors:  Rebecca M Turner; Dan Jackson; Yinghui Wei; Simon G Thompson; Julian P T Higgins
Journal:  Stat Med       Date:  2014-12-05       Impact factor: 2.373

7.  Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?

Authors:  Kristian Thorlund; Lehana Thabane; Edward J Mills
Journal:  BMC Med Res Methodol       Date:  2013-01-11       Impact factor: 4.615

8.  Methods to estimate the between-study variance and its uncertainty in meta-analysis.

Authors:  Areti Angeliki Veroniki; Dan Jackson; Wolfgang Viechtbauer; Ralf Bender; Jack Bowden; Guido Knapp; Oliver Kuss; Julian P T Higgins; Dean Langan; Georgia Salanti
Journal:  Res Synth Methods       Date:  2015-09-02       Impact factor: 5.273

9.  Methods for calculating confidence and credible intervals for the residual between-study variance in random effects meta-regression models.

Authors:  Dan Jackson; Rebecca Turner; Kirsty Rhodes; Wolfgang Viechtbauer
Journal:  BMC Med Res Methodol       Date:  2014-09-06       Impact factor: 4.615

10.  Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data.

Authors:  Kirsty M Rhodes; Rebecca M Turner; Julian P T Higgins
Journal:  J Clin Epidemiol       Date:  2014-10-07       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.